Literature DB >> 11856866

Insertion of a loxP site in a size-reduced human accessory chromosome.

D Moralli1, P Vagnarelli, M Bensi, L De Carli, E Raimondi.   

Abstract

The generation in vitro of mammalian artificial chromosomes, in view of the possibility of developing new technologies for gene therapy, is still an ambitious goal. Mammalian artificial chromosomes, to be used as cloning and expression vectors, have been constructed either by de novo synthesis or by reduction of pre-existing chromosomes. In the work here reported, we introduced a loxP sequence into the pericentromeric region of a chromosome 9-derived X-ray-reduced minichromosome, with the purpose of generating a human chromosome vector (HCV). The modified accessory chromosome is linear and mitotically stable, has lost at least 1400 kb of alpha satellite DNA and normally binds CENP-B, CENP-C and CENP-E. The efficiency of gene targeting via loxP mediated homologous recombination was tested using the histone H2B-Green Fluorescent Protein chimaeric gene as a reporter. The frequency of site-specific insertion of the exogenous sequence was found to be about 50% and to occur in a controlled way with regard to the number of copies. The expression level of the fusion protein was stable over prolonged time in culture. . Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11856866     DOI: 10.1159/000048801

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  6 in total

Review 1.  Artificial and engineered chromosomes: developments and prospects for gene therapy.

Authors:  Brenda R Grimes; Zoia Larin Monaco
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

Review 2.  Human artificial chromosomes for gene delivery and the development of animal models.

Authors:  Yasuhiro Kazuki; Mitsuo Oshimura
Journal:  Mol Ther       Date:  2011-07-12       Impact factor: 11.454

3.  Circular permutation of a synthetic eukaryotic chromosome with the telomerator.

Authors:  Leslie A Mitchell; Jef D Boeke
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-05       Impact factor: 11.205

4.  A mammalian artificial chromosome engineering system (ACE System) applicable to biopharmaceutical protein production, transgenesis and gene-based cell therapy.

Authors:  Michael Lindenbaum; Ed Perkins; Erika Csonka; Elena Fleming; Lisa Garcia; Amy Greene; Lindsay Gung; Gyula Hadlaczky; Edmond Lee; Josephine Leung; Neil MacDonald; Alexisann Maxwell; Kathleen Mills; Diane Monteith; Carl F Perez; Joan Shellard; Sandy Stewart; Tom Stodola; Dana Vandenborre; Sandy Vanderbyl; Harry C Ledebur
Journal:  Nucleic Acids Res       Date:  2004-12-07       Impact factor: 16.971

5.  Plasmodium falciparum GPI mannosyltransferase-III has novel signature sequence and is functional.

Authors:  Suresh H Basagoudanavar; Xiaorong Feng; Gowdahalli Krishnegowda; Arivalagan Muthusamy; D Channe Gowda
Journal:  Biochem Biophys Res Commun       Date:  2007-10-22       Impact factor: 3.575

Review 6.  A pathway from chromosome transfer to engineering resulting in human and mouse artificial chromosomes for a variety of applications to bio-medical challenges.

Authors:  Mitsuo Oshimura; Narumi Uno; Yasuhiro Kazuki; Motonobu Katoh; Toshiaki Inoue
Journal:  Chromosome Res       Date:  2015-02       Impact factor: 5.239

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.